SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-09-001312
Filing Date
2009-02-27
Accepted
2009-02-27 10:25:41
Documents
4
Period of Report
2009-02-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. FORM 8-K b74464ape8vk.htm 8-K 19028
2 EX-10.1 SECURITIES PURCHASE AGREEMENT b74464apexv10w1.htm EX-10.1 153766
3 EX-10.2 LETTER AGREEMENT CATO BIO VENTURES b74464apexv10w2.htm EX-10.2 5645
4 EX-99.1 PRESS RELEASE DATED FEBRUARY 27, 2009 b74464apexv99w1.htm EX-99.1 6872
  Complete submission text file 0000950135-09-001312.txt   187226
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-06533 | Film No.: 09640142
SIC: 2834 Pharmaceutical Preparations